|
GNPDA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
9.38789999960221E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.88769008705003E-13 |
| Stage1-vs-Stage2 |
9.525800E-01 |
| Stage1-vs-Stage3 |
4.523600E-02 |
| Stage1-vs-Stage4 |
3.375700E-04 |
| Stage2-vs-Stage3 |
1.544980E-01 |
| Stage2-vs-Stage4 |
8.955400E-03 |
| Stage3-vs-Stage4 |
4.078100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.74450001298044E-09 |
| Normal-vs-Asian |
6.28199999797019E-08 |
| Caucasian-vs-AfricanAmerican |
2.643800E-02 |
| Caucasian-vs-Asian |
4.623600E-01 |
| AfricanAmerican-vs-Asian |
2.068800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2085445411667E-14 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.552800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.49880108324396E-14 |
| Normal-vs-Age(81-100Yrs) |
1.246250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.324000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.584600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.428000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.222800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.446110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.528020E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.080230E-02 |
| Classical-VS-Follicular |
2.397600E-01 |
| Classical-VS-Other |
9.557800E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
7.843400E-03 |
| Tall-VS-Other |
2.613200E-01 |
| Tall-VS-Normal |
1.24440013848925E-10 |
| Follicular-VS-Other |
7.728400E-01 |
| Follicular-VS-Normal |
3.44149997388854E-09 |
| Other-VS-Normal |
9.841700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62503344114384E-12 |
| Normal-vs-N1 |
3.05089997709729E-09 |
| N0-vs-N1 |
4.621400E-01 |
|
|
